Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Alnylam Pharmaceuticals (ALNY) Q2 2024 Earnings
ALNY
2
May
Confirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-2.21
-0.89
0.42
1.74
Details
Expected EPS
-1.116022
Actual EPS
-0.52
Surprise EPS
0.6
Surprise Percent
+53.41%
Description
Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.52 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login